Strata Skin Sciences Inc (SSKN) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Strata Skin Sciences Inc  (NASDAQ: SSKN)


Strata Skin Sciences Inc's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Strata Skin Sciences Inc's ROI in the fourth quarter of 2025?
Strata Skin Sciences Inc recorded a cumulative net loss of $-6 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -36.91%.

Within the Healthcare sector 601 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from 3660 to 3704.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM -31.51 % -34.13 % -30.34 % -29.42 % -27.83 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 19 16 17 19 22
Return On Investment (TTM) -36.91 % -66.3 % -60.38 % -43.36 % -43.49 %
SSKN's Overall Ranking # 3704 # 3660 # 3108 # 2786 # 3331
Seq. Investment Change TTM -3.81 % -12.54 % -11.38 % -8.13 % -7.49 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -6 -12 -13 -10 -11

SSKN Company Profile >> Back to SSKN Roi Comparisons >> See Annual SSKN Return On Investment



Return On Investment SSKN's Ranking
Within: No.
Industry # 138
Sector # 602
Overall # 3704

Return On Investment Statistics
High Average Low
7.06 %
-51.58 %
-236.54 %
(Sep 30 2021)   (Jun 30 2014)



  News about Strata Skin Sciences Inc Return on Investment ROI

Faith in Future Prospects: STRATA Skin Sciences Raises $2.1 Million in Direct Offering with Insider and Shareholder Participation Amidst Challenging Financial Climate

July 23, 2024


: July 23, 2024
Horsham, PA - STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a leading medical technology company specializing in innovative dermatologic treatments, has recently completed a registered direct offering to raise $2.1 million. The offering, priced at-the-market under Nasdaq rules, saw the issuance and sale of 665,136 shares of common stock at an average purchase price of $3.16 per share.
This is an important development for STRATA as it seeks to navigate the challenging landscape of dermatological conditions. The funds raised in this offering will be used to support the company s ongoing efforts in developing, commercializing, and marketing its innovative products for the treatment of various skin ailments.

STRATA Skin Sciences Makes Striking Comeback with XTRAC Device Placements in First Quarter of 2024

April 30, 2024

STRATA Skin Sciences Announces XTRAC Comeback Placements in the First Quarter of 2024
HORSHAM, Pa., April 30, 2024 - STRATA Skin Sciences, Inc. (STRATA or the Company) (NASDAQ: SSKN), a medical technology company specializing in dermatologic treatments, has recently announced the placement of six XTRAC devices with dermatology clinics in the first quarter of 2024. These placements are considered comebacks, as they involve clinics that were previously part of STRATA s partner program but had terminated their relationship with the company in the past. Notable among these comebacks are Henry Ford Health System in Detroit, Integrated Dermatology Group, and several practices from the Schweiger Dermatology Group.
The XTRAC device developed by STRATA Skin Sciences is an innovative product used for the treatment of dermatologic conditions. It employs excimer technology, which delivers targeted UVB light therapy to affected areas of the skin, specifically targeting and treating plaque psoriasis, vitiligo, and atopic dermatitis. The device has gained significant recognition and positive outcomes in the field of dermatology.





Financial Statements
Strata Skin Sciences Inc's IV. Quarter Investments $ 19 Millions SSKN's Balance sheet
Strata Skin Sciences Inc's IV. Quarter Income $ 0 Millions Quarterly SSKN's Income Statement
SSKN's Income by Division See SSKN's Income by Division


SSKN Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 19 22 30 39 34
Y / Y Investment Growth -12.92 % -27.85 % -23.18 % 14.96 % 20.94 %
Net Income in Millions -6 -10 -11 -6 -3
Y / Y Net Income Growth - - - - -
Annual Return On Investment -33.39 % -46.84 % -36.29 % -14.28 % -8.01 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SSKN's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SSKN's Competitors
Subscribers only: Roi for Strata Skin Sciences Inc's Suppliers
Subscribers only: Return On Investment for SSKN's Customers

Other Ratios
SSKN's Roa SSKN's Inventory Turnover Ratio SSKN's Growth Rates SSKN's Dividend Statistics
SSKN's Profitability Ratios SSKN's Asset Turnover Ratio SSKN's Dividend Growth
SSKN's Roe SSKN's Valuation Ratios SSKN's Financial Strength Ratios SSKN's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI

Date modified: 2026-08-29T07:54:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.